(2026). Lecanemab treatment modulates brain volume and cerebrospinal fluid pathways in early Alzheimer's disease: Insights from longitudinal magnetic resonance imaging. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Lecanemab Treatment Modulates Brain Volume and Cerebrospinal Fluid Pathways in Early Alzheimer's Disease: Insights from Longitudinal Magnetic Resonance Imaging."
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Lecanemab Treatment Modulates Brain Volume and Cerebrospinal Fluid Pathways in Early Alzheimer's Disease: Insights from Longitudinal Magnetic Resonance Imaging."
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.